155 related articles for article (PubMed ID: 7639972)
1. Intravenous versus oral ganciclovir: European/Australian comparative study of efficacy and safety in the prevention of cytomegalovirus retinitis recurrence in patients with AIDS. The Oral Ganciclovir European and Australian Cooperative Study Group.
AIDS; 1995 May; 9(5):471-7. PubMed ID: 7639972
[TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus retinitis in AIDS patients: a comparative study of intravenous and oral ganciclovir as maintenance therapy.
Danner SA; Matheron S
AIDS; 1996 Dec; 10 Suppl 4():S7-11. PubMed ID: 9110064
[TBL] [Abstract][Full Text] [Related]
3. Oral ganciclovir for cytomegalovirus retinitis in patients with AIDS: results of two randomized studies.
Squires KE
AIDS; 1996 Dec; 10 Suppl 4():S13-8. PubMed ID: 9110065
[TBL] [Abstract][Full Text] [Related]
4. Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. Syntex Cooperative Oral Ganciclovir Study Group.
Drew WL; Ives D; Lalezari JP; Crumpacker C; Follansbee SE; Spector SA; Benson CA; Friedberg DN; Hubbard L; Stempien MJ
N Engl J Med; 1995 Sep; 333(10):615-20. PubMed ID: 7637721
[TBL] [Abstract][Full Text] [Related]
5. Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group.
Martin DF; Kuppermann BD; Wolitz RA; Palestine AG; Li H; Robinson CA
N Engl J Med; 1999 Apr; 340(14):1063-70. PubMed ID: 10194235
[TBL] [Abstract][Full Text] [Related]
6. Ganciclovir evaluation in AIDS patients with cytomegalovirus retinitis: a European study of treatment patterns and resource utilization.
Hardens M
AIDS; 1996 Dec; 10 Suppl 4():S25-30. PubMed ID: 9110067
[TBL] [Abstract][Full Text] [Related]
7. Funduscopy versus photographic assessment of cytomegalovirus retinitis progression: a clinician's perspective.
Migdal C
AIDS; 1996 Dec; 10 Suppl 4():S19-23. PubMed ID: 9110066
[TBL] [Abstract][Full Text] [Related]
8. Valganciclovir: new preparation. CMV retinitis: a simpler, oral treatment.
Prescrire Int; 2003 Aug; 12(66):133-5. PubMed ID: 12906021
[TBL] [Abstract][Full Text] [Related]
9. Oral ganciclovir.
Schouten JT
STEP Perspect; 1995; 7(3):1, 11. PubMed ID: 11362979
[TBL] [Abstract][Full Text] [Related]
10. The use of oral ganciclovir in the treatment of cytomegalovirus retinitis in patients with AIDS.
Ward-Able C; Phillips P; Tsoukas CM
CMAJ; 1996 Feb; 154(3):363-8. PubMed ID: 8564906
[TBL] [Abstract][Full Text] [Related]
11. Oral ganciclovir effective for CMV.
Grodeck B
Posit Aware; 1995; ():9. PubMed ID: 11362580
[TBL] [Abstract][Full Text] [Related]
12. A phase II, double-masked, randomized, placebo-controlled evaluation of a human monoclonal anti-Cytomegalovirus antibody (MSL-109) in combination with standard therapy versus standard therapy alone in the treatment of AIDS patients with Cytomegalovirus retinitis.
Borucki MJ; Spritzler J; Asmuth DM; Gnann J; Hirsch MS; Nokta M; Aweeka F; Nadler PI; Sattler F; Alston B; Nevin TT; Owens S; Waterman K; Hubbard L; Caliendo A; Pollard RB;
Antiviral Res; 2004 Nov; 64(2):103-11. PubMed ID: 15498605
[TBL] [Abstract][Full Text] [Related]
13. Treatment of cytomegalovirus retinitis in AIDS patients with intravitreal ganciclovir.
Ausayakhun S; Yuvaves P; Ngamtiphakom S; Prasitsilp J
J Med Assoc Thai; 2005 Nov; 88 Suppl 9():S15-20. PubMed ID: 16681046
[TBL] [Abstract][Full Text] [Related]
14. Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. Roche Cooperative Oral Ganciclovir Study Group.
Spector SA; McKinley GF; Lalezari JP; Samo T; Andruczk R; Follansbee S; Sparti PD; Havlir DV; Simpson G; Buhles W; Wong R; Stempien M
N Engl J Med; 1996 Jun; 334(23):1491-7. PubMed ID: 8618603
[TBL] [Abstract][Full Text] [Related]
15. Treatment of cytomegalovirus retinitis with a sustained-release ganciclovir implant. The Ganciclovir Implant Study Group.
Musch DC; Martin DF; Gordon JF; Davis MD; Kuppermann BD
N Engl J Med; 1997 Jul; 337(2):83-90. PubMed ID: 9211677
[TBL] [Abstract][Full Text] [Related]
16. Incremental cost-effectiveness analysis of intravenous ganciclovir versus oral ganciclovir in the maintenance treatment of newly diagnosed cytomegalovirus retinitis in patients with AIDS.
Rachlis A; Smaill F; Walker V; Hotchkies L; Jones A
Pharmacoeconomics; 1999 Jul; 16(1):71-84. PubMed ID: 10539123
[TBL] [Abstract][Full Text] [Related]
17. [High-dose intravitreal ganciclovir in CMV retinitis].
Cochereau I; Diraison MC; Mousalatti H; Bouyer I; Ren L; Guvenisik N; Hoang-Xuan T
J Fr Ophtalmol; 2000 Feb; 23(2):123-6. PubMed ID: 10705113
[TBL] [Abstract][Full Text] [Related]
18. [Prophylaxis secondary to retinitis by CMV in patients with AIDS: the efficacy of an intermittent schedule of 3 days/week].
Mallolas J; Gatell JM; Gómez-Sirvent JL; Buira E; Zamora L; Alecrim-Andrade J; Adán A; Morales M; Miró JM; Lonća M; Guelar A; Soriano E
Enferm Infecc Microbiol Clin; 1997 Feb; 15(2):61-4. PubMed ID: 9101748
[TBL] [Abstract][Full Text] [Related]
19. Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis.
Rubin RH; Kemmerly SA; Conti D; Doran M; Murray BM; Neylan JF; Pappas C; Pitts D; Avery R; Pavlakis M; Del Busto R; DeNofrio D; Blumberg EA; Schoenfeld DA; Donohue T; Fisher SA; Fishman JA
Transpl Infect Dis; 2000 Sep; 2(3):112-7. PubMed ID: 11429021
[TBL] [Abstract][Full Text] [Related]
20. A randomized prospective trial of oral versus intravenous ganciclovir for prophylaxis of cytomegalovirus infection and disease in high-risk kidney recipients.
Nafar M; Pezeshki ML; Farrokhi F; Einollahi B; Pour-Reza-Gholi F; Firouzan A; Farhangi S
Transplant Proc; 2005 Sep; 37(7):3053-5. PubMed ID: 16213302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
